ROSENWALD LINDSAY A MD (PRESIDENT AND CEO) received a stock award from FORTRESS BIOTECH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001415889-25-000400
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jan 2018
+454.15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
454.15K acquired
Non-Derivative Transactions1
Common stock, par value $0.001
Direct
Shares
+454.15K
Price / share
—
Trade value
—
% of position
12.4%
1/1/2025
3.66M→4.11M
Total
Net shares
+454.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 Direct | 1/1/2025 | A · Award | +454.15K | — | — | 12.4% | 3.66M | 4.11M |
| Total | +454.15K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported